MSIntuit Suite
Suite of AI diagnostic tests covering colorectal, endometrial and gastric cancer screening from pathology slides, marketed as one branded product line on Waiv's own site.
Find alternatives to MSIntuit Suite
Sold to hospitals/labs as a clinical diagnostic suite; no public per-test price. Whether a recurring free tier exists is not stated either way.
What it does
- Data analysis
Sources
- Pricing
-
Official documentation · 14 Sep 2026
Sold to hospitals/labs as a clinical diagnostic suite; no public per-test price. Whether a recurring free tier exists is not stated either way.
- Description
- What it does
- Sold within
-
Own single page covers all three cancer-type variants as one branded suite -- matches the vendor's own catalogue granularity (one page, one name), so proposed as a single record rather than three.
- Name
- URL
Also from Waiv
-
BRCAura RUO Data service
Research-use-only AI test assessing BRCA-related genomic risk signatures from pathology data, sold to research institutions rather than clinical end users.
-
Destra Platform
Workflow platform that orchestrates Waiv's diagnostic tests within a lab's existing pathology workflow, handling sample intake, result delivery and reporting.
-
RlapsRisk BC Data service
CE-IVDR-cleared AI diagnostic test that predicts breast-cancer recurrence risk from routine pathology data, spun out of Owkin's diagnostics division.
Something wrong here? Send a correction — quote this product id: waiv-msintuit-suite.